共 50 条
- [41] Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical TrialsONCOLOGIST, 2012, 17 (02) : 250 - 259Van Driessche, Ann论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium Univ Antwerp, Fac Med, Lab Expt Hematol, Vaccine & Infect Dis Inst VaxInfectio, B-2020 Antwerp, Belgium Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, BelgiumBerneman, Zwi N.论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium Univ Antwerp, Fac Med, Lab Expt Hematol, Vaccine & Infect Dis Inst VaxInfectio, B-2020 Antwerp, Belgium Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, BelgiumVan Tendeloo, Viggo F. I.论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium Univ Antwerp, Fac Med, Lab Expt Hematol, Vaccine & Infect Dis Inst VaxInfectio, B-2020 Antwerp, Belgium Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium
- [42] A Phase I Cardiac Safety and Pharmacokinetic Study of Tivozanib Hydrochloride in Patients With Advanced Solid TumorsCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (04): : 284 - 289Moore, Kathleen论文数: 0 引用数: 0 h-index: 0机构: Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USAInfante, Jeffrey R.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USACotreaua, Monette M.论文数: 0 引用数: 0 h-index: 0机构: AVEO Oncol, Cambridge, MA USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USAWilson, Lindsey论文数: 0 引用数: 0 h-index: 0机构: AVEO Oncol, Cambridge, MA USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USAStrahs, Andrew L.论文数: 0 引用数: 0 h-index: 0机构: AVEO Oncol, Cambridge, MA USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USAVargo, Dennis L.论文数: 0 引用数: 0 h-index: 0机构: AVEO Oncol, Cambridge, MA USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USAChadha, Manpreet论文数: 0 引用数: 0 h-index: 0机构: Virginia G Piper Canc Ctr, Scottsdale, AZ USA TGen, Scottsdale, AZ USA Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
- [43] Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human studyCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (04) : 329 - 339Biesdorf, Carla论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAGuan, Xiaowen论文数: 0 引用数: 0 h-index: 0机构: AbbVie Biotherapeut Inc, South San Francisco, CA USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USASiddani, Satya R.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAHoffman, David论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USABoehm, Nils论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Ludwigshafen, Germany AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAMedeiros, Bruno C.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Biotherapeut Inc, South San Francisco, CA USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USADoi, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAde Jonge, Maja论文数: 0 引用数: 0 h-index: 0机构: Erasmus MC, Rotterdam, Netherlands AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USARasco, Drew论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Res Therapeut START, San Antonio, TX USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAMenon, Rajeev M.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USAPolepally, Akshanth R.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Biotherapeut Inc, South San Francisco, CA USA AbbVie Inc, Clin Pharmacol, 1 North Waukegan Rd,Bldg AP31-3, N Chicago, IL 60064 USA
- [44] A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO-101 in Patients With Advanced Solid TumorsJOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (08) : 878 - 883Stuurman, F. E.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsLolkema, M. P.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Dept Med Oncol, Utrecht, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsHuitema, A. D. R.论文数: 0 引用数: 0 h-index: 0机构: Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsSoetekouw, P. M. M. B.论文数: 0 引用数: 0 h-index: 0机构: Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Div Med Oncol,Dept Internal Med, Maastricht, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsRosing, H.论文数: 0 引用数: 0 h-index: 0机构: Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsRolfe, L.论文数: 0 引用数: 0 h-index: 0机构: Clovis Oncol Inc, Dept Clin Dev, Boulder, CO USA Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsKaur, P.论文数: 0 引用数: 0 h-index: 0机构: Clovis Oncol UK Ltd, Dept Clin Sci, Cambridge, CO USA Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsBeijnen, J. H.论文数: 0 引用数: 0 h-index: 0机构: Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Utrecht, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, Netherlandsvan Tinteren, H.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Biometr Dept, Amsterdam, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsVoest, E. E.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Dept Med Oncol, Utrecht, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, NetherlandsSchellens, J. H. M.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, Netherlands Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Utrecht, Netherlands Netherlands Canc Inst, Div Clin Pharmacol, Amsterdam, Netherlands
- [45] Knowledge, feelings, and willingness to use palliative care in cancer patients with hematologic malignancies and solid tumors: a prospective, cross-sectional study in a comprehensive cancer center in GermanySUPPORTIVE CARE IN CANCER, 2023, 31 (07)Gebel, Cordula论文数: 0 引用数: 0 h-index: 0机构: Jena Univ Hosp, Dept Palliat Care, Jena, Germany Jena Univ Hosp, Dept Palliat Care, Jena, GermanyBasten, Judith论文数: 0 引用数: 0 h-index: 0机构: Jena Univ Hosp, Dept Palliat Care, Jena, Germany Jena Univ Hosp, Dept Palliat Care, Jena, GermanyKruschel, Isabel论文数: 0 引用数: 0 h-index: 0机构: Jena Univ Hosp, Dept Palliat Care, Jena, Germany Jena Univ Hosp, Dept Palliat Care, Jena, GermanyErnst, Thomas论文数: 0 引用数: 0 h-index: 0机构: Jena Univ Hosp, Univ Tumor Ctr, Jena, Germany Jena Univ Hosp, Dept Palliat Care, Jena, GermanyWedding, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Jena Univ Hosp, Dept Palliat Care, Jena, Germany Jena Univ Hosp, Dept Palliat Care, Jena, Germany
- [46] Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumorsCOMMUNICATIONS MEDICINE, 2024, 4 (01):Chen, Jian Jenny论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAVincent, Melanie Y.论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAShepard, Dale论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Cleveland, OH USA Vigeo Therapeut, Cambridge, MA 02140 USAPeereboom, David论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Cleveland, OH USA Vigeo Therapeut, Cambridge, MA 02140 USAMahalingam, Devalingam论文数: 0 引用数: 0 h-index: 0机构: Northwestern Mem Hosp, Chicago, IL USA Vigeo Therapeut, Cambridge, MA 02140 USABattiste, James论文数: 0 引用数: 0 h-index: 0机构: Stephenson Canc Ctr, Oklahoma City, OK USA Vigeo Therapeut, Cambridge, MA 02140 USAPatel, Manish R.论文数: 0 引用数: 0 h-index: 0机构: Florida Canc Specialists Sarah Cannon Res Inst, Sarasota, FL USA Vigeo Therapeut, Cambridge, MA 02140 USAJuric, Dejan论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA USA Vigeo Therapeut, Cambridge, MA 02140 USAWen, Patrick Y.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Vigeo Therapeut, Cambridge, MA 02140 USABullock, Andrea论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Vigeo Therapeut, Cambridge, MA 02140 USASelfridge, Jennifer Eva论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Cleveland Med Ctr, Cleveland, OH USA Vigeo Therapeut, Cambridge, MA 02140 USAPant, Shubham论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Vigeo Therapeut, Cambridge, MA 02140 USALiu, Joyce论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Vigeo Therapeut, Cambridge, MA 02140 USALi, Wendy论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAFyfe, Susanne论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAWang, Suming论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAZota, Victor论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAMahoney, James论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAWatnick, Randolph S.论文数: 0 引用数: 0 h-index: 0机构: Boston Childrens Hosp, Boston, MA USA Vigeo Therapeut, Cambridge, MA 02140 USACieslewicz, Michael论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USAWatnick, Jing论文数: 0 引用数: 0 h-index: 0机构: Vigeo Therapeut, Cambridge, MA 02140 USA Vigeo Therapeut, Cambridge, MA 02140 USA
- [47] Knowledge, feelings, and willingness to use palliative care in cancer patients with hematologic malignancies and solid tumors: a prospective, cross-sectional study in a comprehensive cancer center in GermanySupportive Care in Cancer, 2023, 31Cordula Gebel论文数: 0 引用数: 0 h-index: 0机构: Jena University Hospital,Department of Palliative CareJudith Basten论文数: 0 引用数: 0 h-index: 0机构: Jena University Hospital,Department of Palliative CareIsabel Kruschel论文数: 0 引用数: 0 h-index: 0机构: Jena University Hospital,Department of Palliative CareThomas Ernst论文数: 0 引用数: 0 h-index: 0机构: Jena University Hospital,Department of Palliative CareUlrich Wedding论文数: 0 引用数: 0 h-index: 0机构: Jena University Hospital,Department of Palliative Care
- [48] Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1083 - 1094Chen, Nianhang论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ 07901 USA Celgene Corp, Summit, NJ 07901 USAChawla, Sant P.论文数: 0 引用数: 0 h-index: 0机构: Sarcoma Oncol Ctr, Santa Monica, CA 90403 USA Celgene Corp, Summit, NJ 07901 USAChiorean, Elena Gabriela论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA Celgene Corp, Summit, NJ 07901 USARead, William L.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA Celgene Corp, Summit, NJ 07901 USAGorbaty, Mayer论文数: 0 引用数: 0 h-index: 0机构: Sinai Hosp Baltimore, Randallstown, MD 21133 USA Celgene Corp, Summit, NJ 07901 USAMita, Alain C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA Celgene Corp, Summit, NJ 07901 USAYung, Lotus论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ 07901 USA Celgene Corp, Summit, NJ 07901 USABryan, Peter论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ 07901 USA Celgene Corp, Summit, NJ 07901 USAMcNally, Richard论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ 07901 USA Celgene Corp, Summit, NJ 07901 USARenschler, Markus F.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ 07901 USA Celgene Corp, Summit, NJ 07901 USASharma, Sunil论文数: 0 引用数: 0 h-index: 0机构: Huntsman Canc Inst, Salt Lake City, UT 84112 USA Celgene Corp, Summit, NJ 07901 USA
- [49] A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumorsJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)Chan, Stephen L.论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaSchuler, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, West German Canc Ctr, Essen, Germany Partner Site Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaKang, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaYen, Chia-Jui论文数: 0 引用数: 0 h-index: 0机构: Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Oncol, Tainan, Taiwan Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaEdeline, Julien论文数: 0 引用数: 0 h-index: 0机构: Ctr Eugene Marquis, Rennes, France ARPEGO Acces Rech Precoce Le Grand Ouest Network, Rennes, France Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaChoo, Su Pin论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Singapore, Singapore Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaLin, Chia-Chi论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Taipei, Taiwan Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaOkusaka, Takuji论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Tokyo, Japan Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaWeiss, Karl-Heinz论文数: 0 引用数: 0 h-index: 0机构: Salem Med Ctr, Internal Med, Heidelberg, Germany Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaMacarulla, Teresa论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, IOB Quiron, Barcelona, Spain Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaCattan, Stephane论文数: 0 引用数: 0 h-index: 0机构: Chru Lille, Lille, France Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaBlanc, Jean-Frederic论文数: 0 引用数: 0 h-index: 0机构: CHU Bordeaux Pessac, Bordeaux, France Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaLee, Kyung-Hun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Seoul, South Korea Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaMaur, Michela论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena, Modena, Italy Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaPant, Shubham论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaKudo, Masatoshi论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ Hosp, Osaka, Japan Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaAssenat, Eric论文数: 0 引用数: 0 h-index: 0机构: Hop St Eloi Montpellier, Montpellier, France Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaZhu, Andrew X.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Jiahui Hlth, Jiahui Int Canc Ctr, Shanghai, Peoples R China Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaYau, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Hosp, Hong Kong, Peoples R China Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaLim, Ho Yeong论文数: 0 引用数: 0 h-index: 0机构: Samsung Med Ctr, Seoul, South Korea Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaBruix, Jordi论文数: 0 引用数: 0 h-index: 0机构: Univ Barcelona, Barcelona Clin Liver Canc BCLC Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBERehd, Barcelona, Spain Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaGeier, Andreas论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Wurzburg, Wurzburg, Germany Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaGuillen-Ponce, Carmen论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Ramon Y Cajal, IRYCIS, Madrid, Spain Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaFasolo, Angelica论文数: 0 引用数: 0 h-index: 0机构: Osped San Raffaele, Milan, Italy Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaFinn, Richard S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaFan, Jia论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaVogel, Arndt论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Hannover, Germany Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaQin, Shukui论文数: 0 引用数: 0 h-index: 0机构: 81th PLA Hosp Nanjing, Nanjing, Jiangsu, Peoples R China Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaRiester, Markus论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaKatsanou, Vasiliki论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Basel, Switzerland Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaChaudhari, Monica论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Durham, NC USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaKakizume, Tomoyuki论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma KK, Tokyo, Japan Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaGu, Yi论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaPorta, Diana Graus论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Basel, Switzerland Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaMyers, Andrea论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R ChinaDelord, Jean-Pierre论文数: 0 引用数: 0 h-index: 0机构: IUCT Oncopole Inst Claudius Regaud, Toulouse, France Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China
- [50] Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover studyCancer Chemotherapy and Pharmacology, 2016, 78 : 1003 - 1011Wijith Munasinghe论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologySven Stodtmann论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyAnthony Tolcher论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyEmiliano Calvo论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyMichael Gordon论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyMathilde Jalving论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyJudith de Vos-Geelen论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyDiane Medina论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyDennis Bergau论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologySilpa Nuthalapati论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyDavid Hoffman论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyStacie Shepherd论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental BiologyHao Xiong论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc.,Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology